Aurobindo Pharma Partners with Global Pharma Major for Respiratory Product Development Farhat Nasim25 Nov 2024 3:36 PM ISTAs per the pact, both parties will co-exclusively commercialise the products.
Bayer, Dewpoint ink USD 424 million deal to develop breakthrough therapy for genetic heart disease MD Bureau25 Oct 2024 3:34 PM ISTBerlin: Bayer has signed an exclusive licensing agreement with Dewpoint Therapeutics, Inc. for a heart disease program targeting patients with...
MSD in talks with 5 Indian drugmakers for clinical trial of COVID drug Molnupiravir Medical Dialogues Team30 Jun 2021 5:28 PM ISTNew Delhi: MSD Pharmaceuticals, the wholly owned subsidiary of Merck Sharp Dohme, known as Merck & Co in the US, announced that it has decided to...
Bristol Myers, Dragonfly Therapeutics enter global licensing agreement for IL-12 Investigational Immunotherapy Program Ruchika Sharma20 Aug 2020 9:00 AM ISTNew York & Waltham: Bristol Myers Squibb and Dragonfly Therapeutics, Inc., have announced that they have entered into a definitive...
